These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 8369165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.
    Laman JD, Schellekens MM, Abacioglu YH, Lewis GK, Tersmette M, Fouchier RA, Langedijk JP, Claassen E, Boersma WJ.
    J Virol; 1992 Mar; 66(3):1823-31. PubMed ID: 1637373
    [Abstract] [Full Text] [Related]

  • 3. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P, Earl PL, Sironi F, Santoro F, Ripamonti C, Scarlatti G, Longhi R, Berger EA, Burastero SE.
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [Abstract] [Full Text] [Related]

  • 4. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 5. Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120.
    Connelly RJ, Kahn M, Blake J, Haffar OK, Thomas EK.
    Virology; 1994 Dec 10; 205(2):554-7. PubMed ID: 7526543
    [Abstract] [Full Text] [Related]

  • 6. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.
    Biochem J; 2006 Nov 01; 399(3):483-91. PubMed ID: 16827663
    [Abstract] [Full Text] [Related]

  • 7. A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades.
    Gorny MK, Mascola JR, Israel ZR, VanCott TC, Williams C, Balfe P, Hioe C, Brodine S, Burda S, Zolla-Pazner S.
    AIDS Res Hum Retroviruses; 1998 Feb 10; 14(3):213-21. PubMed ID: 9491911
    [Abstract] [Full Text] [Related]

  • 8. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O, Chill J, Sharon M, Kessler N, Mester B, Zolla-Pazner S, Anglister J.
    Biochemistry; 2005 May 17; 44(19):7250-8. PubMed ID: 15882063
    [Abstract] [Full Text] [Related]

  • 9. Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3.
    Wagner R, Modrow S, Böltz T, Fliessbach H, Niedrig M, von Brunn A, Wolf H.
    Arch Virol; 1992 May 17; 127(1-4):139-52. PubMed ID: 1456889
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.
    Moore JP, Ho DD.
    J Virol; 1993 Feb 17; 67(2):863-75. PubMed ID: 7678308
    [Abstract] [Full Text] [Related]

  • 11. Dual specificity of a human neutralizing monoclonal antibody, specific for the V3 loop of GP120 (HIV-1).
    Laisney IL, Strosberg AD.
    Immunol Lett; 1999 Apr 15; 67(3):185-92. PubMed ID: 10369125
    [Abstract] [Full Text] [Related]

  • 12. Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1.
    Laisney IL, Benjamin H, Gefter M, Strosberg AD.
    Eur J Immunol; 1996 Jul 15; 26(7):1634-40. PubMed ID: 8766572
    [Abstract] [Full Text] [Related]

  • 13. Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.
    Matsushita S, Matsumi S, Yoshimura K, Morikita T, Murakami T, Takatsuki K.
    J Virol; 1995 Jun 15; 69(6):3333-40. PubMed ID: 7538171
    [Abstract] [Full Text] [Related]

  • 14. Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.
    Golding B, Inman J, Highet P, Blackburn R, Manischewitz J, Blyveis N, Angus RD, Golding H.
    J Virol; 1995 Jun 15; 69(6):3299-307. PubMed ID: 7745677
    [Abstract] [Full Text] [Related]

  • 15. Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site.
    Vijh-Warrier S, Pinter A, Honnen WJ, Tilley SA.
    J Virol; 1996 Jul 15; 70(7):4466-73. PubMed ID: 8676471
    [Abstract] [Full Text] [Related]

  • 16. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L, Zolla-Pazner S, Gorny MK, Cheng-Mayer C.
    Virology; 1997 Mar 17; 229(2):360-9. PubMed ID: 9126249
    [Abstract] [Full Text] [Related]

  • 17. A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.
    Zwick MB, Kelleher R, Jensen R, Labrijn AF, Wang M, Quinnan GV, Parren PW, Burton DR.
    J Virol; 2003 Jun 17; 77(12):6965-78. PubMed ID: 12768015
    [Abstract] [Full Text] [Related]

  • 18. A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates.
    Pinter A, Honnen WJ, Racho ME, Tilley SA.
    AIDS Res Hum Retroviruses; 1993 Oct 17; 9(10):985-96. PubMed ID: 7506556
    [Abstract] [Full Text] [Related]

  • 19. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC, Stuber G, Wagner R, Wolf H, Modrow S.
    J Pept Sci; 1995 Oct 17; 1(2):109-23. PubMed ID: 9222988
    [Abstract] [Full Text] [Related]

  • 20. The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1.
    Zolla-Pazner S, Zhong P, Revesz K, Volsky B, Williams C, Nyambi P, Gorny MK.
    AIDS Res Hum Retroviruses; 2004 Nov 17; 20(11):1254-8. PubMed ID: 15588347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.